D.-W. Kim
Impact in
-
- Lung Cancer Treatments and Mutations
- Brain Metastases and Treatment
- Lung Cancer Diagnosis and Treatment
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
Papers in
-
- Lung Cancer Treatments and Mutations 49
- Brain Metastases and Treatment 1
- Oncology 13
- Cancer Immunotherapy and Biomarkers 11
- Co-authors
- Tony S.K. Mok (8 shared papers)Sai‐Hong Ignatius Ou (8 shared papers)Alice Tsang Shaw (10 shared papers)D. Ross Camidge (10 shared papers)Shirish M. Gadgeel (3 shared papers)Walter Bordogna (2 shared papers)Vlatka Smoljanović (2 shared papers)Solange Peters (2 shared papers)
- Journals
- Annals of Oncology (48 papers)Journal of Thoracic Oncology (9 papers)Lung Cancer (1 paper)Osteoporosis International (1 paper)Transplantation Proceedings (1 paper)
- Partner nations
- South KoreaUnited StatesSpain
In The Last Decade
D.-W. Kim
59 papers receiving 2.3k citations
D.-W. Kim's Hit Papers
Peers
Comparison fields: 5 of 69
- Pulmonary and Respiratory Medicine 1.6k
- Oncology 531
- Cancer Research 73
- Economics and Econometrics 58
- Toxicology 10
Countries citing papers authored by D.-W. Kim
This map shows the geographic impact of D.-W. Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.-W. Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.-W. Kim more than expected).
Fields of papers citing papers by D.-W. Kim
This network shows the impact of papers produced by D.-W. Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.-W. Kim. The network helps show where D.-W. Kim may publish in the future.
Co-authors
The 25 scholars most cited alongside D.-W. Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study Hit paper breakdown → | 2020 | 496 |
| 2 | Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial Hit paper breakdown → | 2017 | 439 |
| 3 | 2021 | 231 | |
| 4 | 2014 | 191 | |
| 5 | Safety and efficacy of pralsetinib in RET fusion–positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial Hit paper breakdown → | 2022 | 137 |
| 6 | 2015 | 114 | |
| 7 | 2019 | 86 | |
| 8 | 2020 | 71 | |
| 9 | 2016 | 60 | |
| 10 | 2016 | 37 | |
| 11 | 2024 | 37 | |
| 12 | 2019 | 36 | |
| 13 | 2016 | 35 | |
| 14 | 2018 | 29 | |
| 15 | 2019 | 25 | |
| 16 | 2019 | 25 | |
| 17 | 2019 | 24 | |
| 18 | 2020 | 22 | |
| 19 | 2016 | 18 | |
| 20 | 2018 | 17 |
About D.-W. Kim
D.-W. Kim is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Orthopedics and Sports Medicine, Nephrology and Ophthalmology, having authored 60 papers that have together received 2.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (49 papers), Cancer Immunotherapy and Biomarkers (11 papers), Bone health and osteoporosis research (1 paper), Drug-Induced Ocular Toxicity (1 paper), Fibroblast Growth Factor Research (1 paper), Acute Kidney Injury Research (1 paper), Brain Metastases and Treatment (1 paper) and Hip and Femur Fractures (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.6k citations), Oncology (531 citations), Cancer Research (73 citations), Economics and Econometrics (58 citations) and Toxicology (10 citations). D.-W. Kim has collaborated with scholars based in South Korea, United States and Spain. Frequent co-authors include Tony S.K. Mok, Sai‐Hong Ignatius Ou, Alice Tsang Shaw, D. Ross Camidge, Shirish M. Gadgeel, Walter Bordogna, Vlatka Smoljanović, Solange Peters, Rafał Dziadziuszko and Magalie Hilton. Their work appears in journals such as Annals of Oncology, Journal of Thoracic Oncology, Lung Cancer, Osteoporosis International and Transplantation Proceedings.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.